This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ceneviva, G.
Right arrow Articles by Carcillo, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ceneviva, G.
Right arrow Articles by Carcillo, J. A.
Related Collections
Right arrow Emergency Medicine

PEDIATRICS Vol. 102 No. 2 August 1998, p. e19

ELECTRONIC ARTICLE:
Hemodynamic Support in Fluid-refractory Pediatric Septic Shock

Received Jun 18, 1997; accepted Apr 14, 1998.

Gary Ceneviva*, Dagger , J. Alan Paschallparallel , , Frank MaffeiDagger , and Joseph A. Carcillo*, Dagger , §, parallel

From the Departments of * Anesthesiology and Critical Care Medicine and Dagger  Pediatrics, and the § Center for Clinical Pharmacology, University of Pittsburgh, Pittsburgh, Pennsylvania; the parallel  Department of Anesthesiology and Critical Care Medicine, Children's National Medical Center, Washington, DC; and the  Department of Pediatric Critical Care Medicine, Mary Bridge Children's Hospital, Tacoma, Washington.

Objective.  Assess outcome in children treated with inotrope, vasopressor, and/or vasodilator therapy for reversal of fluid-refractory and persistent septic shock.

Design.  Survey; case series.

Setting.  Three pediatric hospitals.

Patients.  Fifty consecutive patients with fluid-refractory septic shock with a pulmonary artery catheter within 6 hours of resuscitation.

Interventions.  Patients were categorized according to hemodynamic state and use of inotrope, vasopressor, and/or vasodilator therapy to maintain cardiac index (CI) >3.3 L/min/m2 and systemic vascular resistance >800 dyne-sec/cm/m to reverse shock.

Outcome Measures.  Hemodynamic state, response to class of cardiovascular therapy, and mortality.

Results.  After fluid resuscitation, 58% of the children had a low CI and responded to inotropic therapy with or without a vasodilator (group I), 20% had a high CI and low systemic vascular resistance and responded to vasopressor therapy alone (group II), and 22% had both vascular and cardiac dysfunction and responded to combined vasopressor and inotropic therapy (group III). Shock persisted in 36% of the children. Of the children in group I, 50% needed the addition of a vasodilator, and in group II, 50% of children needed the addition of an inotrope for evolving myocardial dysfunction. Four children showed a complete change in hemodynamic state and responded to a switch from inotrope to vasopressor therapy or vice versa. The overall 28-day survival rate was 80% (group I, 72%; group II, 90%; group III, 91%).

Conclusions.  Unlike adults, children with fluid-refractory shock are frequently hypodynamic and respond to inotrope and vasodilator therapy. Because hemodynamic states are heterogeneous and change with time, an incorrect cardiovascular therapeutic regimen should be suspected in any child with persistent shock. Outcome can be improved compared with historical literature.

Key words: inotropes, vasodilators, vasopressors, septic shock, hemodynamics.




This article has been cited by other articles:


Home page
 EDUCATION AND PRACTICEHome page
K Cathie, M Levin, and S N Faust
Drug use in acute meningococcal disease
Arch. Dis. Child. Ed. Pract., October 1, 2008; 93(5): 151 - 158.
[Full Text] [PDF]

Home page
 PerfusionHome page
S. L Augustin, S. Horton, C. Thuys, M. Bennett, C. Claessen, and C. Brizard
The use of extracorporeal life support in the treatment of influenza-associated myositis/rhabdomyolysis
Perfusion, March 1, 2006; 21(2): 121 - 125.
[Abstract] [PDF]

Home page
 CirculationHome page
Part 12: Pediatric Advanced Life Support
Circulation, December 13, 2005; 112(24_suppl): IV-167 - IV-187.
[Full Text] [PDF]

Home page
 Anesth. Analg.Home page
R. J. Levy, R. M. Chiavacci, S. C. Nicolson, J. J. Rome, R. J. Lin, M. A. Helfaer, and V. M. Nadkarni
An Evaluation of a Noninvasive Cardiac Output Measurement Using Partial Carbon Dioxide Rebreathing in Children
Anesth. Analg., December 1, 2004; 99(6): 1642 - 1647.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
P. C. Minneci, K. J. Deans, S. M. Banks, R. Costello, G. Csako, P. Q. Eichacker, R. L. Danner, C. Natanson, and S. B. Solomon
Differing effects of epinephrine, norepinephrine, and vasopressin on survival in a canine model of septic shock
Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2545 - H2554.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
I. Sajan, S. S. Da-Silva, and R. P. Dellinger
Drotrecogin Alfa (Activated) in an Infant with Gram-Negative Septic Shock
J Intensive Care Med, January 1, 2004; 19(1): 51 - 55.
[Abstract] [PDF]

Home page
 Arch. Dis. Child.Home page
S M Tibby and I A Murdoch
Monitoring cardiac function in intensive care
Arch. Dis. Child., January 1, 2003; 88(1): 46 - 52.
[Abstract] [Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
S. M. Schexnayder
Pediatric Septic Shock
Pediatr. Rev., September 1, 1999; 20(9): 303 - 308.
[Full Text]